LetterLetter
COVID-19 in Children With Rheumatic Diseases in the Spanish National Cohort EPICO-AEP
Cristina Calvo, Clara Udaondo and the Rheumatic Diseases EPICO-AEP Working Group
The Journal of Rheumatology February 2021, jrheum.201548; DOI: https://doi.org/10.3899/jrheum.201548
Cristina Calvo
Pediatric and Infectious Disease Unit, Hospital Universtiario La Paz and La Paz Research Institute (IdiPaz); Traslational Research Network of Pediatric Infectious Diseases (RITIP); Pediatric Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain. This study has been partially funded by a grant from the Spanish Association of Pediatrics (AEP) and by the Spanish Health Research Fund (Grant Nº PI20/00995). The authors declare no conflicts of interest. Address correspondence to Dr. C. Calvo, Hospital Universitario La Paz, Pº Castellana, 261.28046 Madrid, Spain. Email: ccalvorey@gmail.com.
Clara Udaondo
Pediatric and Infectious Disease Unit, Hospital Universtiario La Paz and La Paz Research Institute (IdiPaz); Traslational Research Network of Pediatric Infectious Diseases (RITIP); Pediatric Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain. This study has been partially funded by a grant from the Spanish Association of Pediatrics (AEP) and by the Spanish Health Research Fund (Grant Nº PI20/00995). The authors declare no conflicts of interest. Address correspondence to Dr. C. Calvo, Hospital Universitario La Paz, Pº Castellana, 261.28046 Madrid, Spain. Email: ccalvorey@gmail.com.
Pediatric and Infectious Disease Unit, Hospital Universtiario La Paz and La Paz Research Institute (IdiPaz); Traslational Research Network of Pediatric Infectious Diseases (RITIP); Pediatric Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain. This study has been partially funded by a grant from the Spanish Association of Pediatrics (AEP) and by the Spanish Health Research Fund (Grant Nº PI20/00995). The authors declare no conflicts of interest. Address correspondence to Dr. C. Calvo, Hospital Universitario La Paz, Pº Castellana, 261.28046 Madrid, Spain. Email: ccalvorey@gmail.com.
This article has a correction. Please see:
Abstract
SARS-CoV-2 infection in children is relatively mild. Approximately 10% of identified cases are pediatric,1 with a small proportion needing hospitalization. About 25–60% of children admitted with the coronavirus disease 2019 (COVID-19) have comorbidities.2,3.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
COVID-19 in Children With Rheumatic Diseases in the Spanish National Cohort EPICO-AEP
Cristina Calvo, Clara Udaondo, the Rheumatic Diseases EPICO-AEP Working Group
The Journal of Rheumatology Feb 2021, jrheum.201548; DOI: 10.3899/jrheum.201548